Future Healthcare Story

Personalized Medicine Market Trend Analysis, Share Analysis, Gross Margin Analysis, Cost Structure Analysis and Forecast to 2026

Press release   •   Mar 11, 2020 02:11 EDT

According to Acumen Research, The global ​Personalized Medicine Market is estimated to represent a global market of US$ 1.7 Trillion by 2026 with a growth rate of 9.1% during the forecast era 2019 to 2026. The report provides analysis of global Personalized Medicine Market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

The report is intended to help stakeholders get an executive-level blueprint of the global market. It contains information obtained from trusted industrial sources. Besides this, expert opinions find an importance mention in the report. Predictions and estimations included in the report are obtained using industry-leading analytical tools. Furthermore, the report compiles results from in-depth qualitative and quantitative analyses. The information thus acquired is compiled in a logical chapter-wise manner to ensure improved readability.


Qualitative Analyses

Quantitative Analyses
Porter’s Five Forces Analysis Industry Share Analysis
Market Growth Opportunities Market Size and Forecast, by Application
Completive Landscape Market Size and Forecast, by Type
Current Industry Trends Market Size and Forecast, by Product
Competition Analysis Market Size and Forecast, by Region

The report offers a bird’s eye view of the Personalized Medicine Market, gauging its growth trajectory over the years. It presents insights into key factors boosting the markets, besides the ones restricting its growth. The report also highlights hidden opportunities for the market besides revealing the key restraints. It is therefore intended to help market players determine their growth strategies and make informed decisions pertaining to potential investments.

The Personalized Medicine Market study provides a thorough assessment of the present market trends that influences the market growth. The research also involves the industry's market valuation in terms of revenue, forecast data, geographic spectrum, competitive landscape and SWOT analysis. Furthermore, the study describes major challenges and growth opportunities faced by market players in conjunction with their product offerings and business strategies. This study focuses on North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa top competitors.

​Click Here To Get FREE SAMPLE PDF (Including Full TOC, Table & Figures)

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2019. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

List of Companies

The report lists down some of the leading companies operating in this market. The market share of the global Personalized Medicine Market is dominated by companies like Illumina, Inc.; Danaher Corporation Asuragen, Inc.; Abbott Laboratories; GE Healthcare; Dako A/S; Exagen Diagnostics, Inc.; Exact Science Corporation;Decode Genetics, Inc.; QIAGEN; Celera Diagnostics LLC; Genelex Corporation; Precision Biologics, Inc.; and Biogen, Inc.

The policies adopted by these companies are studied in detail. Furthermore, the report offers insights into their product portfolio, pricing strategies, strategic collaborations, mergers and acquisitions, among others.

SWOT Analysis is conducted on the companies listed to study their strengths and weaknesses. Furthermore, the analysis offered insights into opportunities and threats present in the market for these companies. A comparative analysis between these companies is intended to highlight the most successful strategies adopted by these companies. Doing so, the report offers recommendations for growth to companies operating in the market. It is thus conducted to help companies, irrespective of their size, access relevant information.

Market Segment Analysis:

Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of this market.

Market Segmentation’s as below:

Market, By Product

  • Therapeutics
  • Diagnostics
  • Personalized Nutrition & Wellness
  • Personalized Medical Care

Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Personalized Medicine Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Personalized Medicine market segments with market dynamics and their impact. The report also covers basic technology development policies.

This Report offers an assessment of the most recent developments in each sub-segment from 2015 until 2026 and offers a forecast of revenues and volume growth at worldwide, regional and national levels. ARC segmented the worldwide personalized medicine (PM) report on the product and region for the purpose of this research:

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global Personalized Medicine Market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Personalized Medicine
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Personalized Medicine Market By Product
1.2.2.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Personalized Medicine Market Revenue Share By Product in 2017
1.2.2.3. Therapeutics
1.2.2.4. Diagnostics
1.2.2.5. Personalized Nutrition & Wellness
1.2.2.6. Personalized Medical Care
1.2.3. Personalized Medicine Market by Geography
1.2.3.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Personalized Medicine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Personalized Medicine Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Personalized Medicine Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Personalized Medicine Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Personalized Medicine Major Manufacturers in 2017

CHAPTER 4. PERSONALIZED MEDICINE MARKET BY PRODUCT

4.1. Global Personalized Medicine Revenue By Product
4.2. Therapeutics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Diagnostics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Personalized Nutrition & Wellness
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Personalized Medical Care
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY

5.1. North America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Personalized Medicine Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE PERSONALIZED MEDICINE MARKET BY COUNTRY

6.1. Europe Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET BY COUNTRY

7.1. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY

8.1. Latin America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST PERSONALIZED MEDICINE MARKET BY COUNTRY

9.1. Middle East Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA PERSONALIZED MEDICINE MARKET BY COUNTRY

10.1. Africa Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Illumina, Inc.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Danaher Corporation
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Asuragen, Inc.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. GE Healthcare
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Dako A/S
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Exagen Diagnostics, Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Exact Science Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Decode Genetics, Inc.
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. QIAGEN
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Celera Diagnostics LLC
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Genelex Corporation
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Precision Biologics, Inc.
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
11.14. Biogen, Inc.
11.14.1. Company Snapshot
11.14.2. Overview
11.14.3. Financial Overview
11.14.4. Product Portfolio
11.14.5. Key Developments
11.14.6. Strategies
11.15. Others
11.15.1. Company Snapshot
11.15.2. Overview
11.15.3. Financial Overview
11.15.4. Product Portfolio
11.15.5. Key Developments
11.15.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1466

Contact Us:

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Acumen Industry Reports:

Healthcare and Pharmaceuticals

Chemicals and Materials

Automotive, Transportation and Logistics

Packaging

ICT